Significados de dysmyelopoietic syndrome en inglés

We report two THC2 patients misdiagnosed with myelodysplasia and treated with chemotherapy.

Cytopenia at day 30 was not significantly associated with later diagnosis of myelodysplasia.

Bone marrow biopsy done 3 months prior showed no significant myelodysplasia or lymphoid aggregates.

Results in myelodysplasia and aplastic anemia have been less encouraging.

However, there are very limited data on the development of hemophagocytosis or myelodysplasia in these patients.

Ten patients with preleukemia and life-threatening pancytopenia were treated with marrow transplantation.

Specimens were obtained from patients with preleukemia and associated antigen weakening, and from individuals with normal antigen values.

This experience also emphasizes the importance of performing chromosome studies before transplantation for pancytopenic states in order to identify cases of preleukemia.

A myelodysplastic syndrome was noted 83 months from the start of therapy.

With these techniques, we studied a 61-year-old woman with a myelodysplastic syndrome.

Case reports: A 76-year-old male with a known myelodysplastic syndrome presented with pneumonia.

Additionally, two patients with primary mediastinal germ cell cancer developed a myelodysplastic syndrome.

Sixteen children with myelodysplastic syndrome as defined by the French-American-British co-operative group are presented.

Acute myeloid leukemia and myelodysplastic syndromes represented the most common disease indications.

Objective: Unbalanced chromosomal aberrations are common in myelodysplastic syndromes and have prognostic implications.

All patients belonged to the more aggressive subtypes of myelodysplastic syndromes.

The relationship between these cytopenias and myeloid neoplasms like myelodysplastic syndromes is currently poorly defined.

Results: Many rare germline mutations have been identified that lead to acute leukemia and myelodysplastic syndromes.